This study examines the price, conditions of purchase, and basic quality of five popular drugs purchased over the Internet.

Knowing where all our ingredients come from is the first step toward improving drug quality.

Differential pricing is necessary to provide suffering people in poor countries access to needed medicines and ensure that medical innovation will continue in the future.

The crisis in financing is having a chilling effect on biomedical innovation. As discussed in my last column, the main problem in our industry is that the sheer cost of drug development has become almost prohibitively expensive, effectively pricing almost everyone but the largest companies out of the market.

Biopharma – especially big pharma – gets all sorts of grief for being large, stodgy, and unable to innovate (or evolve); this Corey Goodman interview represents the perspective well.

Before writing off these companies entirely, however (an ignorant reaction in any case),...

Until government price controls are lifted, the makers of generics will be unable to cover their production costs.

Americans pay more--often a lot more--for drugs than Canadians and Europeans. That is unfair, but wholesale importation of drugs from these locations isn't the answer.

Failing to distinguish between licensed online pharmacies (Canadian or otherwise), which require a valid prescription and sell safe medications, and rogue online pharmacies, which sell lethal fake medicines or flout prescription requirements, means poor patients have less information to make good choices about the drugs they require.